Skip to main content
. 2019 Feb;11(2):521–534. doi: 10.21037/jtd.2019.01.19

Table S4. Meta-regression results of different variables on all and high grades.

Pneumonitis Beta ± SE, P value
All studies Only NSCLC Among anti-PD-1
All grade pneumonitis
   Age 0.2798±0.2411, P=0.2459 0.4290±0.3231, P=0.1842 0.2663±0.2433, P=0.2738
   Female% 0.0210±0.0348, P=0.5452 −0.0663±0.0883, P=0.4526 0.0180±0.0354, P=0.6110
   PS ≥1 −0.0380±0.0260, P=0.1440 0.0866±0.1266, P=0.4943 −0.0378±0.0260, P=0.1459
   Smokers 0.0954±0.0588, P=0.1043 0.0946±0.0651, P=0.1461 0.0952±0.0588, P=0.1051
   RTH −0.0162±0.1463, P=0.9117 −0.0162±0.1463, P=0.9117 -0.0162±0.1463, P=0.9117
High grade pneumonitis
   Age 0.4080±0.2269, P=0.0721 0.0415±0.3712, P=0.9110 0.3856±0.2286, P=0.0916
   Female% 0.0254±0.0319, P=0.4265 0.0351±0.0970, P=0.7177 0.0194±0.0329, P=0.5565
   PS ≥1 −0.0239±0.0448, P=0.5937 −0.0148±0.1421, P=0.9173 −0.0229±0.0448, P=0.6087
   Smokers 0.0051±0.0701, P=0.9416 −0.0023±0.0753, P=0.9762 0.0080±0.0702, P=0.9095
   RTH −0.0727±0.1545, P=0.6381 −0.0727±0.1545, P=0.6381 −0.0727±0.1545, P=0.6381

*, positive beta reflects an increase in pneumonitis with increase in the variable, while negative beta reflects a decrease in pneumonitis with increase in the variable; , those in italic show trends toward statistical significance. NSCLC, non-small cell lung cancer; PS, performance status; RTH, radiotherapy; SE, slandered error.